» Articles » PMID: 25621661

Diseases of Pulmonary Surfactant Homeostasis

Overview
Journal Annu Rev Pathol
Publisher Annual Reviews
Specialty Pathology
Date 2015 Jan 27
PMID 25621661
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in physiology and biochemistry have provided fundamental insights into the role of pulmonary surfactant in the pathogenesis and treatment of preterm infants with respiratory distress syndrome. Identification of the surfactant proteins, lipid transporters, and transcriptional networks regulating their expression has provided the tools and insights needed to discern the molecular and cellular processes regulating the production and function of pulmonary surfactant prior to and after birth. Mutations in genes regulating surfactant homeostasis have been associated with severe lung disease in neonates and older infants. Biophysical and transgenic mouse models have provided insight into the mechanisms underlying surfactant protein and alveolar homeostasis. These studies have provided the framework for understanding the structure and function of pulmonary surfactant, which has informed understanding of the pathogenesis of diverse pulmonary disorders previously considered idiopathic. This review considers the pulmonary surfactant system and the genetic causes of acute and chronic lung disease caused by disruption of alveolar homeostasis.

Citing Articles

A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patients.

Ito M, Honda T, Onishi I, Endo S, Mochizuki A, Nishiyama N ERJ Open Res. 2025; 11(1).

PMID: 40008177 PMC: 11849094. DOI: 10.1183/23120541.00628-2024.


Cholesterol sensing and metabolic adaptation in tissue immunity.

Dang E, Reboldi A Trends Immunol. 2024; 45(11):861-870.

PMID: 39424470 PMC: 11560508. DOI: 10.1016/j.it.2024.09.013.


Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants.

Hong K, Shin S, Kim E, Kim H BMC Pediatr. 2024; 24(1):467.

PMID: 39033281 PMC: 11264936. DOI: 10.1186/s12887-024-04943-4.


Childhood interstitial lung diseases: current understanding of the classification and imaging findings.

Tsujioka Y, Nishimura G, Nishi E, Kono T, Nozaki T, Hashimoto M Jpn J Radiol. 2024; 42(9):937-952.

PMID: 39012450 PMC: 11364587. DOI: 10.1007/s11604-024-01603-6.


A Comprehensive Outlook on Pulmonary Alveolar Proteinosis-A Review.

Woloszczak J, Wrzesniewska M, Hrapkowicz A, Janowska K, Szydziak J, Gomulka K Int J Mol Sci. 2024; 25(13).

PMID: 39000201 PMC: 11241585. DOI: 10.3390/ijms25137092.


References
1.
Avital A, Hevroni A, Godfrey S, Cohen S, Maayan C, Nusair S . Natural history of five children with surfactant protein C mutations and interstitial lung disease. Pediatr Pulmonol. 2013; 49(11):1097-105. DOI: 10.1002/ppul.22971. View

2.
Ikegami M, Whitsett J, Jobe A, Ross G, Fisher J, Korfhagen T . Surfactant metabolism in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol. 2000; 279(3):L468-76. DOI: 10.1152/ajplung.2000.279.3.L468. View

3.
Alameh J, Bachiri A, Devisme L, Truffert P, Rakza T, Riou Y . Alveolar capillary dysplasia: a cause of persistent pulmonary hypertension of the newborn. Eur J Pediatr. 2002; 161(5):262-6. DOI: 10.1007/s00431-002-0927-7. View

4.
Perl A, Wert S, Nagy A, Lobe C, Whitsett J . Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A. 2002; 99(16):10482-7. PMC: 124949. DOI: 10.1073/pnas.152238499. View

5.
Whitsett J, Weaver T . Hydrophobic surfactant proteins in lung function and disease. N Engl J Med. 2002; 347(26):2141-8. DOI: 10.1056/NEJMra022387. View